Nashik, July 04: In a remarkable demonstration of surgical precision and perseverance, the team at HCG Manavata Cancer Centre (HCGMCC), successfully performed a complex 9-hour surgery to remove a massive recurrent retroperitoneal tumour weighing nearly 15 kilograms. The tumour had returned for the fourth time, making the case exceptionally rare and challenging. Despite the high complexity of the case, Prof. Dr Raj Nagarkar and his team successfully achieved an R0 resection which is the complete removal of the tumour with no residual cancer cells. The procedure involved small bowel resection, ileo-transverse anastomosis and a repair of the common iliac vein, with the patient making a smooth recovery and being discharged on post-operative day 7.

Resident of Dhule, the 61-year-old male patient had previously undergone multiple surgeries, each involving critical organs including the right colon, right kidney and gallbladder to remove earlier tumour recurrences. This time, the mass had expanded extensively, involving nearly the entire abdomen, with tumour deposits in the pelvis, lesser sac, greater sac and dense adhesion to the small bowel mesentery.

“Retroperitoneal sarcomas are rare and often aggressive cancers that tend to recur. Each recurrence increases surgical complexity due to scarring, loss of normal anatomical planes, izmir sex shop and organ involvement. Achieving a complete resection in such cases significantly improves long-term outcomes for the patient. Operating on a tumour of this scale, especially after multiple previous surgeries, demands careful planning, technical mastery and above all, commitment to the patient’s life and future,” says Prof Dr Raj Nagarkar, Chief of Surgical Oncology & Robotic Services and Managing Director - KIMS Manavata Hospitals, HCG Manavata Cancer Centre and Six Sigma, Nashik.

The case redefines surgical possibilities through three critical achievements. First, its recurrence resilience demanded innovative approaches to navigate dense scar tissue and severe anatomical distortions from four prior tumour removals. Second, multidisciplinary mastery through seamless collaboration between surgical oncology, vascular surgery and critical care teams ensuring millimetre-level precision during the complex resection and vascular repair. Finally, the patient was discharged just seven days after surgery. This demonstrates minimized surgical trauma and validates HCGMCC’s enhanced recovery protocols, proving that even extreme interventions can align with patient-centric healing.

“Beyond the technical triumph, the case embodies our ethos - no cancer is untreatable. When a patient endures four recurrences, our duty isn’t just to operate, it’s to restore hope. The case is a powerful reminder of what surgical persistence and precision can achieve and a patient’s recovery in just seven days fuels our resolve to push boundaries,” concludes Dr Nagarkar.

About HCG Manavata Cancer Centre (HCGMCC): -

Established in 2007 by Dr Raj Nagarkar, HCGMCC – Nashik is Central India's first NABH-accredited facility. With over 54 consultant oncologists, 900 staff members and a 275-bed capacity, HCGMCC is a leading institution, offering holistic cancer treatment. Specializing in surgical, radiation and medical oncology, the centre has conducted 95,000 surgeries, including 1,600 plus robotic-assisted procedures. Patient-centric and multidisciplinary, HCGMCC recommends treatments to individual needs. Beyond clinical excellence, the centre’s financial aid programs underscore its commitment to accessibility and community well-being, redefining cancer care in the pursuit of a cancer-free future.